ТОП просматриваемых книг сайта:
Evidence in Medicine. Iain K. Crombie
Читать онлайн.Название Evidence in Medicine
Год выпуска 0
isbn 9781119794196
Автор произведения Iain K. Crombie
Жанр Медицина
Издательство John Wiley & Sons Limited
17 17. Schulz, K.F., Chalmers, I., Hayes, R.J. et al. (1995). Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 273: 408–412.
18 18. Dechartres, A., Trinquart, L., Faber, T. et al. (2016). Empirical evaluation of which trial characteristics are associated with treatment effect estimates. J. Clin. Epidemiol. 77: 24–37.
19 19. Pansieri, C., Pandolfini, C., and Bonati, M. (2015). The evolution in registration of clinical trials: a chronicle of the historical calls and current initiatives promoting transparency. Eur. J. Clin. Pharmacol. 71: 1159–1164.
20 20. Zarin, D.A., Tse, T., Williams, R.J. et al. (2017). Update on trial registration 11 years after the ICMJE policy was established. N. Engl. J. Med. 376: 383–391.
21 21. Howard, B., Scott, J.T., Blubaugh, M. et al. (2017). Systematic review: outcome reporting bias is a problem in high impact factor neurology journals. PLoS One https://doi.org/10.1371/journal.pone.0180986.
22 22. Wayant, C., Scheckel, C., Hicks, C. et al. (2017). Evidence of selective reporting bias in hematology journals: a systematic review. PLoS One https://doi.org/10.1371/journal.pone.0178379.
23 23. Hannink, G., Gooszen, H.G., and Rovers, M.M. (2013). Comparison of registered and published primary outcomes in randomized clinical trials of surgical interventions. Ann. Surg. 257: 818–823.
24 24. Raghav, K.P., Mahajan, S., Yao, J.C. et al. (2015). From protocols to publications: a study in selective reporting of outcomes in randomized trials in oncology. J. Clin. Oncol. 33: 3583–3590.
25 25. Dwan, K., Gamble, C., Williamson, P.R. et al. (2013). Systematic review of the empirical evidence of study publication bias and outcome reporting bias – an updated review. PLoS One https://doi.org/10.1371/journal.pone.0066844.
26 26. Li, G., Abbade, L.P.F., Nwosu, I. et al. (2018). A systematic review of comparisons between protocols or registrations and full reports in primary biomedical research. BMC Med. Res. Methodol. https://doi.org/10.1186/s12874‐017‐0465‐7.
27 27. Chen, T., Li, C., Qin, R. et al. (2019). Comparison of clinical trial changes in primary outcome and reported intervention effect size between trial registration and publication. JAMA Netw. Open https://doi.org/10.1001/jamanetworkopen.2019.7242.
28 28. Smyth, R.M., Kirkham, J.J., Jacoby, A. et al. (2011). Frequency and reasons for outcome reporting bias in clinical trials: interviews with trialists. BMJ https://doi.org/10.1136/bmj.c7153.
29 29. van der Steen, J.T., van den Bogert, C.A., van Soest‐Poortvliet, M.C. et al. (2018). Determinants of selective reporting: a taxonomy based on content analysis of a random selection of the literature. PLoS One https://doi.org/10.1371/journal.pone.0188247.
30 30. Bello, S., Moustgaard, H., and Hrobjartsson, A. (2017). Unreported formal assessment of unblinding occurred in 4 of 10 randomized clinical trials, unreported loss of blinding in 1 of 10 trials. J. Clin. Epidemiol. 81: 42–50.
31 31. Bello, S., Moustgaard, H., and Hrobjartsson, A. (2014). The risk of unblinding was infrequently and incompletely reported in 300 randomized clinical trial publications. J. Clin. Epidemiol. 67: 1059–1069.
32 32. Yi, J., Haibo, H.L., Li, Y. et al. (2020). Risk of bias and its impact on intervention effect estimates of randomized controlled trials in endodontics. J. Endodontics 46: 12–18.
33 33. Moustgaard, H., Clayton, G.L., Jones, H.E. et al. (2020). Impact of blinding on estimated treatment effects in randomised clinical trials: meta‐epidemiological study. BMJ https://doi.org/10.1136/bmj.l6802.
34 34. Huupponen, R. and Viikari, J. (2013). Statins and the risk of developing diabetes. BMJ https://doi.org/10.1136/bmj.f3156.
35 35. Tang, E., Ravaud, P., Riveros, C. et al. (2015). Comparison of serious adverse events posted at http://ClinicalTrials.gov and published in corresponding journal articles. BMC Med. https://doi.org/10.1186/s12916‐015‐0430‐4.
36 36. Favier, R. and Crepin, S. (2018). The reporting of harms in publications on randomized controlled trials funded by the “Programme Hospitalier de Recherche Clinique,” a French academic funding scheme. Clin. Trials 15: 257–267.
37 37. Hughes, S., Cohen, D., and Jaggi, R. (2014). Differences in reporting serious adverse events in industry sponsored clinical trial registries and journal articles on antidepressant and antipsychotic drugs: a cross‐sectional study. BMJ Open https://doi.org/10.1136/bmjopen‐2014‐005535.
38 38. Golder, S., Loke, Y.K., Wright, K. et al. (2016). Reporting of adverse events in published and unpublished studies of health care interventions: a systematic review. PLoS Med. https://doi.org/10.1371/journal.pmed.1002127.
39 39. Hodkinson, A., Kirkham, J.J., Tudur‐Smith, C. et al. (2013). Reporting of harms data in RCTs: a systematic review of empirical assessments against the CONSORT harms extension. BMJ Open https://doi.org/10.1136/bmjopen‐2013‐003436.
40 40. Fewtrell, M.S., Kennedy, K., Singhal, A. et al. (2008). How much loss to follow‐up is acceptable in long‐term randomised trials and prospective studies? Arch. Dis. Child. 93: 458–461.
41 41. Schulz, K.F. and Grimes, D.A. (2002). Sample size slippages in randomised trials: exclusions and the lost and wayward. Lancet 359: 781–785.
42 42. Akl, E.A., Briel, M., You, J.J. et al. (2012). Potential impact on estimated treatment effects of information lost to follow‐up in randomised controlled trials (LOST‐IT): systematic review. BMJ https://doi.org/10.1136/bmj.e2809.
43 43. Zhang, Y., Florez, I.D., Colunga Lozano, L.E. et al. (2017). A systematic survey on reporting and methods for handling missing participant data for continuous outcomes in randomized controlled trials. J. Clin. Epidemiol. 88: 57–66.
44 44. Nuesch, E., Trelle, S., Reichenbach, S. et al. (2009). The effects of excluding patients from the analysis in randomised controlled trials: meta‐epidemiological study. BMJ https://doi.org/10.1136/bmj.b3244.
45 45. Bell, M.L., Fiero, M., Horton, N.J. et al. (2014). Handling missing data in RCTs; a review of the top medical journals. BMC Med. Res. Methodol. https://doi.org/10.1186/1471‐2288‐14‐118.
46 46. Walters, S.J., Bonacho Dos Anjos Henriques‐Cadby, I., Bortolami, O. et al. (2017). Recruitment and retention of participants in randomised controlled trials: a review of trials funded and published by the United Kingdom Health Technology Assessment Programme. BMJ Open https://doi.org/10.1136/bmjopen‐2016‐015276.
47 47. Hussain, J.A., White, I.R., Langan, D. et al. (2016). Missing data in randomized controlled trials testing palliative interventions pose a significant risk of bias and loss of power: a systematic review and meta‐analyses.